Dapagliflozin, a Selective SGLT2 Inhibitor, Improves Glucose Homeostasis in Normal and Diabetic Rats

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

FIG. 5.
FIG. 5.

Dapagliflozin lowers fasting and fed plasma glucose over 15 days of once-daily oral treatment in ZDF rats. Graphic, Vehicle; ▪, 0.01 mg/kg; Graphic, 0.1 mg/kg; □, 1 mg/kg. *P < 0.0001, †P < 0.05, each vs. vehicle.

This Article

  1. Diabetes vol. 57 no. 6 1723-1729